|
Real-time Estimate
Cboe BZX
11:17:53 2026-10-22 EDT
|
5-day change | 1st Jan Change | ||
| 18.80 USD | +0.94% |
|
-5.25% | -13.71% |
| 09-15 | Health Care Down, But Not by Much, on Rotation to Less Inflation-Sensitive Areas -- Health Care Roundup | DJ |
| 09-15 | Legend Biotech Corporation Announces CEO Changes | CI |
| Market Cap | 3.61B 3.22B 2.98B 2.7B 5.08B 341B 5.14B 35.71B 14.01B 179B 13.54B 13.26B 571B | P/E 2026 * |
-1,748x | P/E 2027 * | 27.3x |
|---|---|---|---|---|---|
| Enterprise Value | 2.65B 2.36B 2.19B 1.98B 3.73B 250B 3.77B 26.22B 10.29B 131B 9.94B 9.74B 419B | EV / Sales 2026 * |
1.84x | EV / Sales 2027 * | 1.41x |
| Free-Float |
98.75% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| LEGN | Delayed | |
CBOE
| LEGN | Real-time | |
Tradegate
| 9LB | Real-time | |
Boerse Muenchen
| 9LB | Real-time | |
Deutsche Boerse AG
| 9LB | Delayed | |
Börse Stuttgart
| 9LB | Delayed |
Last Transcript: Legend Biotech Corporation
| 1 day | +0.94% | ||
| 1 week | -5.25% | ||
| Current month | -5.68% | ||
| 1 month | +0.64% | ||
| 3 months | -20.27% | ||
| 6 months | -27.65% | ||
| Current year | -13.71% |
| 1 week | 18 | 19.77 | |
| 1 month | 17.56 | 20 | |
| Current year | 16.24 | 37.5 | |
| 1 year | 16.24 | 37.5 | |
| 3 years | 16.24 | 70.13 | |
| 5 years | 16.24 | 77.32 | |
| 10 years | 16.24 | 77.32 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ingrid Zhang
CEO | Chief Executive Officer | 53 | 2026-09-14 |
Carlos Garcia
DFI | Director of Finance/CFO | 54 | 2025-08-17 |
Elizabeth Martin
CMP | Compliance Officer | 53 | 2026-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Ye Wang
CHM | Chairman | 57 | 2020-11-05 |
Corazon Sanders
BRD | Director/Board Member | 69 | 2020-04-30 |
Xiao Hui Ji
BRD | Director/Board Member | 63 | 2020-04-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/29/26 | Sell | Director | -27,370 | 0.0095% | ||
| 9/24/26 | Free | Director | 20,986 | 0.0073% | ||
| 9/24/26 | Free | Director | 28,330 | 0.0098% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.94% | -5.25% | -41.58% | -71.31% | 3.61B | ||
| -4.10% | -8.35% | +38.48% | +66.99% | 66.22B | ||
| +1.02% | +4.59% | +11.87% | +75.96% | 55.2B | ||
| +0.98% | +4.44% | +12.61% | +92.49% | 52.79B | ||
| +0.67% | +2.98% | +28.12% | +51.94% | 45.53B | ||
| -1.33% | +1.85% | +21.52% | +125.80% | 43.94B | ||
| -3.40% | -1.64% | +251.36% | +914.17% | 41.64B | ||
| -1.67% | +8.06% | +14.17% | +56.67% | 34B | ||
| -8.38% | -9.01% | +25.65% | -1.82% | 25.84B | ||
| +1.30% | +4.94% | +38.23% | +28.03% | 23.51B | ||
| Average | -1.41% | +2.81% | +40.04% | +133.89% | 39.23B | |
| Weighted average by Cap. | -1.48% | +3.34% | +47.05% | +157.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.44B 1.28B 1.19B 1.07B 2.02B 136B 2.05B 14.22B 5.58B 71.32B 5.39B 5.28B 227B | 1.77B 1.58B 1.46B 1.32B 2.5B 167B 2.53B 17.55B 6.89B 88.02B 6.66B 6.52B 280B |
| Net income | -12.18M -10.86M -10.05M -9.1M -17.14M -1.15B -17.34M -121M -47.28M -604M -45.7M -44.75M -1.93B | 198M 177M 164M 148M 279M 18.71B 282M 1.96B 770M 9.84B 744M 728M 31.34B |
| Net Debt | -959M -855M -792M -716M -1.35B -90.54B -1.37B -9.49B -3.72B -47.59B -3.6B -3.52B -152B | -1.12B -994M -921M -833M -1.57B -105B -1.59B -11.04B -4.33B -55.35B -4.19B -4.1B -176B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-22 | US$18.78 | +0.81% | 381,648 |
| 26-10-21 | US$18.63 | -2.00% | 1,560,137 |
| 26-10-20 | US$19.01 | +1.93% | 1,137,163 |
| 26-10-19 | US$18.65 | +0.92% | 1,894,711 |
| 26-10-16 | US$18.48 | -6.67% | 2,961,906 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LEGN Stock
Select your edition
All financial news and data tailored to specific country editions

















